Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.
Browsing Center for Life Sciences by Author "Nurgozhin, T."
-
Shulgau, Z.; Gulyayev, A.; Yermekbayeva, B.; Adilgozhina, G.; Tritek, V.; Nurgozhin, T.
(Clinical Therapeutics, 2015-08-01)
Present study aimed to investigate possible cardioprotective properties of polyphenol concentrates obtained from Cabernet Sauvignon type of Kazakhstani grapes using rat model doxorubicin-induced cardiomyopathy.
-
Gulyayev, A.; Shulgau, Z.; Yermekbayeva, B.; Sergazy, S.; Nurgozhin, T.
(Clinical Therapeutics, 2015-08-01)
-
Bektur, C.; Nurgozhin, T.
(2014-05-01)
-
Kostyuk, A.; Nurgozhin, T.; Mazhitov, T.; Almadiyeva, A.
(Value in Health, 2014-05-01)
-
Nurgozhin, T.; Gulyayev, A.; Lokhvytsky, S.; Yermekbayeva, B.; Sergazy, S.; Shulgau, Z.; Berikkhanova, K.
(Clinical Therapeutics, 2015-08-01)
-
Nurgozhin, T.; Gulyaev, A.; Yermekbayeva, B.; Kushugulova, A.; Akhmetova, A.; Supiev, A.
(2013-11-01)
-
Almadiyeva, A.; Ibrayev, S.; Turgambayeva, A.; Nurgozhin, T.
(2016-11-01)
-
Bektur, C.; Nurgozhin, T.
(2014-11-01)
A phase III clinical trial demonstrated the advantage of denosumab over zoledronic acid(ZA) in delaying the first on-study and subsequent skeletal-related events(SREs) in patients with prostate cancer(PC). Recently, generic ...